ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109825; 2) Community: the network communities that were significantly associated with the response to NSC 109825; 3) Molecule: the relationships between components within communities and NSC 109825; 4) MDR: the compounds that were significantly associated with the NSC 109825.

NSC Compound Enrichment Correlation
NSC 725191 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol 0.0339770934764508 -0.26225341
NSC 736164 pyrazoline derivative 0.0339770934764508 -0.20829826
NSC 749292 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine 0.0339770934764508 -0.24180403
NSC 756698 Clomiphene citrate (USAN) 0.0339770934764508 0.026934953
NSC 1 Methylbenzoquinone 0.0339770934764516 -0.20959699
NSC 18300 Null 0.0352028253287042 0.13179952
NSC 27445 Null 0.0352028253287042 0.32809903
NSC 405159 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, 4-oxo-.alpha.-phenyl-, oxime 0.0352028253287042 -0.23931534
NSC 606699 Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt 0.0352028253287042 0.043920466
NSC 622294 Null 0.0352028253287042 -0.10577505
Total:59  Current:36    [First] [Prev] [Next] [Last]